This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Entopharm Co., Ltd., Other. Active years: 2004-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Essen, DE (2004 - 2008)
- Moscow, RU (2013 - 2021)
Company Filing History:
Years Active: 2004-2021
Title: German Petrovich Bekker: Innovator in Antitumor Pharmacology
Introduction
German Petrovich Bekker is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of pharmacology, particularly in the development of antitumor agents. With a total of 4 patents, Bekker's work focuses on innovative compositions that aim to combat cancer effectively.
Latest Patents
Among his latest patents is a composition for preparing an anti-tumor agent, which is designed for injection. This composition includes alloferon at a concentration of 0.05 to 0.1% wt, cis-diamminedichloridoplatinum at a concentration of 0.01 to 0.05% wt, and water. The invention is characterized by its antitumor activity and hypotoxicity. Another significant patent involves antitumoral and antiviral peptides, which consist of novel compositions that produce an antitumoral and antiviral effect by suppressing tumor cell proliferation and stimulating immunologic mechanisms.
Career Highlights
Throughout his career, Bekker has worked with various companies, including Entopharm Co., Ltd. His innovative approaches and research have positioned him as a key figure in the development of effective pharmacological solutions.
Collaborations
Bekker has collaborated with notable individuals in his field, including Sergey Ivanovich Chernysh and Soo In Kim. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
German Petrovich Bekker's contributions to pharmacology, particularly in the realm of antitumor agents, highlight his innovative spirit and dedication to improving cancer treatment. His patents reflect a commitment to advancing medical science and providing effective solutions for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile